Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links related to guidelines are provided separately. (See "Society guideline links: Crohn disease in adults" and "Society guideline links: Ulcerative colitis in adults" and "Society guideline links: Gastrointestinal bleeding in children".)
Links to guidelines related to coronavirus disease 2019 (COVID-19) are also provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)
International
●International Organization for the Study of Inflammatory Bowel Disease (IOIBD): Dietary guidance for the study of inflammatory bowel diseases (2020)
●World Gastroenterology Organisation (WGO): Global guidelines on inflammatory bowel disease, update (2015)
Canada
●Choosing Wisely Canada: Gastroenterology - Ten things clinicians and patients should question (2021)
●North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): A position paper on anemia in children with inflammatory bowel disease (2020)
●NASPGHAN: Position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease (2020)
●Canadian Association of Gastroenterology (CAG): Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease – The Toronto Consensus (2018)
●NASPGHAN: Clinical report for assuring quality for non-hospital-based biologic infusions in pediatric inflammatory bowel disease (2018)
●NASPGHAN: Clinical report on the role of combination therapy in pediatric inflammatory bowel disease (2018)
●NASPGHAN: Clinical report on hepatic issues and complications associated with inflammatory bowel disease (2017)
●NASPGHAN: Clinical report on postoperative recurrence in pediatric Crohn disease (2017)
●NASPGHAN: Clinical report for surveillance, diagnosis, and prevention of infectious diseases in pediatric patients with inflammatory bowel disease receiving tumor necrosis factor-alpha inhibitors (2016)
●NASPGHAN: Clinical report and consensus statement for the diagnosis and treatment of perianal Crohn disease (2013)
●NASPGHAN: Clinical report for self-management in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on psychosocial issues in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on the evaluation and treatment of pediatric patients with internal penetrating Crohn disease − Intraabdominal abscess with and without fistula (2013)
●NASPGHAN: Clinical report on the role of thiopurine methyltransferase determination in pediatric IBD (2013)
●NASPGHAN: Recommendations for health supervision in the management of children and adolescents with IBD (2012)
●NASPGHAN: Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease (2012)
●NASPGHAN: Skeletal health of children and adolescents with inflammatory bowel disease (2011)
●CAG: Clinical practice guidelines on the use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease (2009)
●NASPGHAN and Crohn's and Colitis Foundation of America (CCF): Clinical report for differentiating ulcerative colitis from Crohn disease in children and young adults (2007)
United States
●American Society of Colon and Rectal Surgeons (ASCRS): Clinical practice guidelines for the surgical management of ulcerative colitis (2021)
●North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN): A position paper on anemia in children with inflammatory bowel disease (2020)
●NASPGHAN: Position paper on the evaluation and management for patients with very early-onset inflammatory bowel disease (2020)
●NASPGHAN: Clinical report for assuring quality for non-hospital-based biologic infusions in pediatric inflammatory bowel disease (2018)
●NASPGHAN: Clinical report on the role of combination therapy in pediatric inflammatory bowel disease (2018)
●American College of Gastroenterology (ACG): Clinical guideline on preventive care in inflammatory bowel disease (2017)
●NASPGHAN: Clinical report on hepatic issues and complications associated with inflammatory bowel disease (2017)
●NASPGHAN: Clinical report on postoperative recurrence in pediatric Crohn disease (2017)
●NASPGHAN: Clinical report for surveillance, diagnosis, and prevention of infectious diseases in pediatric patients with inflammatory bowel disease receiving tumor necrosis factor-alpha inhibitors (2016)
●ASCRS: Clinical practice guideline for the surgical management of Crohn's disease (2015)
●NASPGHAN: Clinical report and consensus statement for the diagnosis and treatment of perianal Crohn disease (2013)
●NASPGHAN: Clinical report for self-management in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on psychosocial issues in pediatric inflammatory bowel disease (2013)
●NASPGHAN: Clinical report on the evaluation and treatment of pediatric patients with internal penetrating Crohn disease − Intraabdominal abscess with and without fistula (2013)
●NASPGHAN: Clinical report on the role of thiopurine methyltransferase determination in pediatric IBD (2013)
●NASPGHAN: Recommendations for health supervision in the management of children and adolescents with IBD (2012)
●NASPGHAN: Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease (2012)
●NASPGHAN: Skeletal health of children and adolescents with inflammatory bowel disease (2011)
●NASPGHAN and Crohn's and Colitis Foundation of America (CCF): Clinical report for differentiating ulcerative colitis from Crohn disease in children and young adults (2007)
Europe
●European Crohn's and Colitis Organization (ECCO): Guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease (2021)
●European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): A position paper on clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease (2021)
●ESPGHAN: A position paper on the use of fecal calprotectin testing in paediatric disorders (2021)
●ECCO-ESPGHAN: Guideline for the medical management of paediatric Crohn's disease, update (2020)
●ESPGHAN: Updated position statement for the use of biosimilars in pediatric inflammatory disease (2019)
●ESPGHAN: Position paper on endoscopy in pediatric inflammatory bowel disease (2018)
●ESPGHAN: Position paper on nutrition in pediatric inflammatory bowel disease (2018)
●ECCO and ESPGHAN: An evidence-based guideline for the management of paediatric ulcerative colitis − Part 1: Ambulatory Care (2018)
●ECCO and ESPGHAN: An evidence-based consensus guideline for the management of paediatric ulcerative colitis − Part 2: Acute severe colitis (2018)
●ESPGHAN: Guidelines for the surgical management of Crohn disease in children (2017)
●ESPGHAN: Society guideline on the revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents (2014)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on Crohn's disease – Management (2019)
●NICE: Guideline on ulcerative colitis – Management (2019)
●NICE: Quality standard on inflammatory bowel disease (2015)
Australia-New Zealand
●Gastroenterological Society of Australia (GESA): Clinical update for general practitioners and physicians – Inflammatory bowel disease (2018)
Japan
●Japanese Society for Pediatric Gastroenterology, Hepatology, and Nutrition (JSPGHAN): Guidelines for the treatment of Crohn's disease in children (2006)
●JSPGHAN: Guidelines for the treatment of ulcerative colitis in children (2004)
